Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study.

Saved in:
Bibliographic Details
Title: Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study.
Authors: Styczynski J; Department of Pediatric Hematology, Oncology, Immunology and Transplantology; Jurasz University Hospital 1, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland. jstyczynski@cm.umk.pl., Tridello G; EBMT Leiden Study Unit, Leiden, The Netherlands., Verheggen I; EBMT Leiden Study Unit, Leiden, The Netherlands., Knelange N; EBMT Leiden Study Unit, Leiden, The Netherlands., Wendel L; EBMT Leiden Study Unit, Leiden, The Netherlands., Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, and Department of Infectious Diseases, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Department of Medicine Huddinge, Karolinska Institutet Stockholm, Stockholm, Sweden., Piñana JL; Department of Hematology. Hospital Clínico Universitario of Valencia, INCLIVA, Biomedical Research Institute, Valencia, Spain., Mikulska M; Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Gil L; Department of Hematology, Poznan University of Medical Sciences, Poznan, Poland., Cesaro S; Pediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy., Ciceri F; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy., Greco R; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy., Wu D; First Affiliated Hospital of Soochow University, Suzhou, China., Blaise D; Transplant and cellular immunotherapy program, Department of Hematology, Institut Paoli Calmettes, Sport Cancer Management lab, Aix Marseille University, Marseille, France., Cerretti R; Fondazione Policlinico Tor Vergata, Rome, Italy., Chevallier P; CHU Nantes, Nantes, France., Forcade E; CHU Bordeaux, Hopital Haut-Leveque, Pessac, France., Sicre de Fontbrune F; Saint-Louis Hospital, BMT Unit, Paris, France., Mohty M; Sorbonne University, Hopital Saint Antoine, INSERM UMRs 938, Paris, France., Ducastelle Lepretre S; Hopital Lyon Sud, Hospices Civils de Lyon, Lyon, France., Bulabois CE; CHU Grenoble Alpes-Universite Grenoble Alpes, Grenoble, France., Nguyen Quoc S; Universite Paris IV, Hopital la Pitie-Salpetriere, Paris, France., Yakoub-Agha I; CHU de Lille, University of Lille, INSERM U1286, Infinite, Lille, France., de la Camara R; Hospital de la Princesa, Madrid, Spain., Averbuch D; Faculty of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Source: Bone marrow transplantation [Bone Marrow Transplant] 2026 Jul; Vol. 61 (7), pp. 941-943. Date of Electronic Publication: 2026 May 04.
Publication Type: Letter
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1476-5365
DOI:10.1038/s41409-026-02898-x